-
Biomednewsbreaks - Kairos Pharma Ltd. (NYSE American: KAPA) Secures Dod Grant To Advance Lung Cancer Biomarker Research
17 Apr 2025 19:37 GMT
… ENV105 in EGFR-driven non-small cell lung cancer. The study focuses on patients … a Phase 1 trial for lung cancer, addressing significant unmet medical needs …
-
Kairos Pharma Ltd. Announces Department of Defense Grant to Support Its Study of Lead Compound ENV105 to Prevent Drug Resistance in Lung Cancer
17 Apr 2025 12:24 GMT
… involved in treating EGFR-driven lung cancer patients with ENV105 in combination … recent breakthroughs in understanding non-small cell lung cancer mechanism of resistance to first … achieving a lasting cure for lung cancer patients. The grant was awarded …
-
Targeted Sequencing Reveals Asian Lung Cancer Variants
17 Apr 2025 09:30 GMT
… suffering from non-small-cell lung cancer (NSCLC). This … in Asian non-small-cell lung cancer patients Article Title: … variants in Asian non-small-cell lung cancer Article References:
Wang … Tags: Asian non-small-cell lung cancer variantscancer diagnostics in …
-
More Options, More Questions: How Pharmacists Are Managing EGFR-Positive Non-Small Cell Lung Cancer
15 Apr 2025 19:41 GMT
… the treatment of non-small cell lung cancer (NSCLC), particularly the … know, patients with metastatic lung cancer will always progress. So, … drug conjugates coming into lung cancer, and so that’s … these EGFR-mutant non-small cell lung cancer patients. So, we’ …
-
Antibody-Based Therapeutics in Small Cell Lung Cancer: A Narrative Review
15 Apr 2025 14:11 GMT
…
Small-cell lung cancer (SCLC) is the most aggressive form of lung cancer … in patients with small cell lung cancer. Lung Cancer. 2018;115: … in patients with small cell lung cancer. Lung Cancer. 2020;147:237 … metastatic small cell lung cancers and patient-derived …
-
Medicaid expansion improves access to high-volume hospitals for lung cancer patients
16 Apr 2025 17:16 GMT
… patients with early-stage non-small cell lung cancer (NSCLC). These findings underscore … associated with an increase in lung cancer surgeries performed at high-volume … to timely and high-quality lung cancer treatment nationwide.
Medicaid expansion continues …
-
ORYZON Announces First Patient Dosed in NCI-Sponsored Phase I/II Clinical Trial of Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer
15 Apr 2025 12:00 GMT
… ) in first line small cell lung cancer (SCLC) patients with extensive … With Extensive-Stage Small Cell Lung Cancer”, will evaluate the … tumors such as small cell lung cancer (SCLC), neuroendocrine tumors (NET … second line ED-SCLC patients (CLEPSIDRA trial …
-
Amgen shares positive phase 3 results for Imdelltra in small cell lung cancer
15 Apr 2025 11:27 GMT
… immunotherapy Imdelltra (tarlatamab-dlle) in small cell lung cancer (SCLC).
The global DeLLphi-304 trial … are diagnosed with lung cancer globally every year, with SCLC accounting for … platinum-based chemotherapy, most SCLC patients relapse within months and …
-
Cost-Effectiveness Analysis of Serplulimab Combined with Nab-Paclitaxel Plus Carboplatin Compared to Nab-Paclitaxel Plus Carboplatin Alone as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer in China
14 Apr 2025 14:59 GMT
… lung cancer cases and 766,898 lung cancer-related deaths in China.2 Non-small cell lung cancer … (NSCLC) accounts for the majority (80% - 85%) of all lung cancers …
-
Medicaid Expansion Enhances Timely Lung Cancer Care and Access to Leading Hospitals
16 Apr 2025 01:32 GMT
… -stage non-small cell lung cancer (NSCLC). … lung cancer treatmentearly-stage non-small cell lung cancer … surgery trendsMedicaid expansion and healthcare accessMedicaid expansion impact on lung cancer … in lung cancer patientssurgical …
About
© 1995-2025